Aquatic Capital Management LLC boosted its position in Dolby Laboratories, Inc. (NYSE:DLB - Free Report) by 1,036.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,592 shares of the electronics maker's stock after buying an additional 19,692 shares during the period. Aquatic Capital Management LLC's holdings in Dolby Laboratories were worth $1,686,000 as of its most recent SEC filing.
Several other institutional investors also recently bought and sold shares of DLB. Fifth Third Bancorp boosted its stake in shares of Dolby Laboratories by 82.7% in the fourth quarter. Fifth Third Bancorp now owns 360 shares of the electronics maker's stock valued at $28,000 after buying an additional 163 shares in the last quarter. Nisa Investment Advisors LLC lifted its holdings in Dolby Laboratories by 436.2% in the fourth quarter. Nisa Investment Advisors LLC now owns 370 shares of the electronics maker's stock valued at $29,000 after acquiring an additional 301 shares during the period. Mather Group LLC. boosted its position in shares of Dolby Laboratories by 36.8% during the 4th quarter. Mather Group LLC. now owns 528 shares of the electronics maker's stock worth $41,000 after purchasing an additional 142 shares in the last quarter. Headlands Technologies LLC acquired a new position in shares of Dolby Laboratories during the 4th quarter worth $57,000. Finally, GAMMA Investing LLC increased its holdings in shares of Dolby Laboratories by 207.5% in the 4th quarter. GAMMA Investing LLC now owns 778 shares of the electronics maker's stock valued at $61,000 after purchasing an additional 525 shares in the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Dolby Laboratories
In other Dolby Laboratories news, CAO Ryan Nicholson sold 7,000 shares of Dolby Laboratories stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $84.07, for a total transaction of $588,490.00. Following the transaction, the chief accounting officer now directly owns 29,758 shares of the company's stock, valued at $2,501,755.06. The trade was a 19.04 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CMO Todd Pendleton sold 18,121 shares of the stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $83.75, for a total value of $1,517,633.75. Following the completion of the sale, the chief marketing officer now owns 37,290 shares of the company's stock, valued at approximately $3,123,037.50. This represents a 32.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 38.39% of the stock is owned by company insiders.
Dolby Laboratories Stock Performance
NYSE:DLB traded down $0.10 during mid-day trading on Monday, hitting $74.77. 84,156 shares of the company's stock traded hands, compared to its average volume of 475,070. The firm's 50 day simple moving average is $77.73 and its 200 day simple moving average is $78.37. Dolby Laboratories, Inc. has a 1 year low of $66.35 and a 1 year high of $89.66. The company has a market cap of $7.14 billion, a PE ratio of 27.49 and a beta of 0.94.
Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The electronics maker reported $1.34 earnings per share for the quarter, beating analysts' consensus estimates of $1.29 by $0.05. Dolby Laboratories had a net margin of 19.97% and a return on equity of 11.32%. The business had revenue of $369.56 million during the quarter, compared to analyst estimates of $375.44 million. During the same quarter in the previous year, the business posted $1.27 earnings per share. The company's revenue was up 1.4% on a year-over-year basis. On average, research analysts expect that Dolby Laboratories, Inc. will post 2.94 earnings per share for the current fiscal year.
Dolby Laboratories Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 21st. Shareholders of record on Tuesday, May 13th will be paid a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 1.77%. The ex-dividend date is Tuesday, May 13th. Dolby Laboratories's payout ratio is 48.53%.
Analyst Ratings Changes
DLB has been the topic of a number of research analyst reports. Barrington Research reissued an "outperform" rating and set a $100.00 price objective on shares of Dolby Laboratories in a report on Friday. Rosenblatt Securities decreased their price target on Dolby Laboratories from $100.00 to $95.00 and set a "buy" rating on the stock in a research note on Friday. Finally, StockNews.com downgraded Dolby Laboratories from a "strong-buy" rating to a "buy" rating in a research note on Friday, January 31st.
View Our Latest Analysis on Dolby Laboratories
About Dolby Laboratories
(
Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Featured Articles

Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.